Skip to content

The effect of topical chamomile herbal product on the symptoms of patients with muscle cramps

The effect of topical chamomile herbal product on the symptoms of patients with leg cramps in comparison with standard treatment: a double-blind clinical trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200105046009N7
Enrollment
64
Registered
2023-01-09
Start date
2023-01-20
Completion date
Unknown
Last updated
2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

muscle cramp. Cramp and spasm

Interventions

Intervention 1: Chamomile topical product (combination of chamomile oil and wax made in the laboratory of the Iranian Faculty of Medicine) in the amount of one knuckle every eight hours is used topica

Sponsors

Babol University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Men and women aged 20 to 60 years Presence of muscle cramp in the gastrocnemius muscle The presence of pain with a vas score greater than six

Exclusion criteria

Exclusion criteria: Lack of complete evaluation to monitor the treatment process Lack of satisfaction during treatment The presence of underlying diseases related to cramps Using other painkillers Performing procedures that lead to the improvement of muscle cramps History of recurrent cramps without clear cause

Design outcomes

Primary

MeasureTime frame
Pain index. Timepoint: The VAS measurement is measured before the intervention and on even days after the start of the intervention, and the treatment continues until the pain index reaches 4 or a change of 1.7 based on the MCID. Method of measurement: Pain intensity measurement using VAS tool.;Duration of treatment. Timepoint: VAS is measured before the intervention and on even days after the start of the intervention, and the examination of the pain index continues until the day it reaches the number 4 or the change rate of 1.7 based on the MCID. Method of measurement: Pain intensity measurement using VAS tool.

Secondary

MeasureTime frame
Redness. Timepoint: Measurements are taken before the intervention and on even days after the start of the intervention, and the treatment continues until the pain index reaches 4 or a change of 1.7 based on the MCID. Method of measurement: By patient report or evaluator observation.;Itching. Timepoint: Measurements are taken before the intervention and on even days after the start of the intervention, and the treatment continues until the pain index reaches 4 or a change of 1.7 based on the MCID. Method of measurement: By patient report or evaluator observation.;Swelling. Timepoint: Measurements are taken before the intervention and on even days after the start of the intervention, and the treatment continues until the pain index reaches 4 or a change of 1.7 based on the MCID. Method of measurement: By patient report or evaluator observation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyyed Ali Mozaffarpur

Babol University of Medical Sciences

dr.mozaffarpur@mubabol.ac.ir+98 11 3219 4728

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026